Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Antoniou, A., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H. +25 more·2003·The American Journal of Human Genetics
DOI 10.1086/375033

Cited by (1,009)

Items 901–1,000 of 1,009

  1. Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation
    Amber J. Willems, Sarah‐Jane Dawson, Hemamali Samaratunga, Alessandro De Luca, Yoland C. Antill, John Llewelyn Hopper, Heather Thorne, and kConFab Investigators · 2008 · Clinical Cancer Research
  2. Can genes for mammographic density inform cancer aetiology?
    Linda E. Kelemen, Thomas A. Sellers, Celine M. Vachon · 2008 · Nature reviews. Cancer
  3. Women's Perceptions of the Personal and Family Impact of Genetic Cancer Risk Assessment: Focus Group Findings
    Deborah J. MacDonald, Linda P. Sarna, Jeffrey N. Weitzel, BETTY ROLLING FERRELL · 2009 · Journal of Genetic Counseling
  4. Breast cancer genetic counseling after diagnosis but before treatment: A pilot study on treatment consequences and psychological impact
    Marijke R. Wevers, Daniela E. E. Hahn, Senno Verhoef, Marijke D.K. Bolhaar, Margreet G.E.M. Ausems, Neil K. Aaronson, Eveline M. A. Bleiker · 2012 · Patient Education and Counseling
  5. A Randomized, Controlled Trial to Increase Discussion of Breast Cancer in Primary Care
    Celia Patricia Kaplan, Jennifer Livaudais‐Toman, Jeffrey A. Tice, Karla M. Kerlikowske, Steven E. Gregorich, Eliseo J. Pérez‐Stable, Rena J. Pasick, Alice P. Chen, Jessica Quinn, Leah Karliner · 2014 · Cancer Epidemiology Biomarkers & Prevention
  6. Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy – A review of the literature
    Rachael Glassey, Angela D. Ives, Christobel Mary Saunders, Toni Musiello · 2016 · The Breast
  7. DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities
    Mallika Dhawan, Charles J. Ryan, Alan Ashworth · 2016 · The Oncologist
  8. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    Jacob McGee, Vasily Giannakeas, Beth Y. Karlan, Jan Lubiński, Jacek Gronwald, Barry P. Rosen, John R McLaughlin, Harvey A. Risch, Ping Sun, William David Foulkes et al. · 2017 · Gynecologic Oncology
  9. Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review
    Nadin Younes, Hatem Zayed · 2018 · Gene
  10. Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
    Anurag Mehta, Smreti Vasudevan, Sanjeev Kumar Sharma, Dushyant Kumar, Manoj Kumar Panigrahi, Moushumi Suryavanshi, Garima Gupta · 2018 · Cancer Management and Research
  11. The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
    Lars Asphaug, Hans Olav Melberg · 2019 · MDM Policy & Practice
  12. Design choices for observational studies of the effect of exposure on disease incidence
    Mitchell H. Gail, Douglas G. Altman, Suzanne M. Cadarette, Professor Gary S. Collins, Stephen J. W. Evans, Peggy Sekula, Elizabeth Williamson, Mark Woodward · 2019 · BMJ Open
  13. Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
    Maria Isabel Achatz, Maira M Caleffi, Rodrigo Santa Cruz Guindalini, Renato Moretti‐Marques, Angélica Nogueira‐Rodrigues, Patrícia Ashton‐Prolla · 2020 · JCO Global Oncology
  14. DNA helicases and their roles in cancer
    Srijita Dhar, Arindam Datta, Robert M. Brosh · 2020 · DNA repair
  15. Methodological and clinical challenges associated with biomarkers for psychiatric disease: A scoping review
    Kirkpatrick, Ryan H., Munoz, Douglas P., Khalid-Khan, Sarosh, Booij, Linda · 2021 · Journal of Psychiatric Research
  16. Adverse Selection in Term Life Insurance Purchasing due to the BRCA1/2 Genetic Test and Elastic Demand
    Krupa S. Viswanathan, Jean Lemaire, Kate H. Withers, Katrina Armstrong, Agnieszka Baumritter, John C. Hershey, Mark V. Pauly, David A. Asch · 2007 · Journal of Risk & Insurance
  17. Health Behaviors and Psychological Distress in Women Initiating BRCA1/2 Genetic Testing: Comparison with Control Population
    Michel Dorval, Karine Bouchard, Elizabeth Maunsell, Marie Plante, Jocelyne Chiquette, Stéphanie Camden, Michel J. Dugas, Jacques Simard, INHERIT BRCAs · 2008 · Journal of Genetic Counseling
  18. BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
    Jadwiga Rogozińska-Szczepka, Beata Utracka-Hutka, Ewa Anna Grzybowska, Bogusław Maka, Elżbieta Nowicka, Anna Smok-Ragankiewicz, Helena Zientek, Jan A. Steffen, A. Wojciechowska-Łącka · 2004 · Annals of Oncology
  19. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer
    Yoland Catherine Antill, John Reynolds, Mary‐Anne Young, Judy Kirk, Kathy Tucker, Tarli L. Bogtstra, Shirley Wong, Tracy E Dudding, Juliana Di Iulio, Kelly‐Anne Phillips · 2006 · European Journal of Cancer
  20. Genetic Testing and the Family
    Marcia L. Van Riper · 2005 · Journal of Midwifery & Women s Health
  21. Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage
    Joonyoung Her, Nam Soo Lee, Yonghwan Kim, Hongtae Kim · 2016 · Acta Biochimica et Biophysica Sinica
  22. Minority Recruitment in Hereditary Breast Cancer Research
    Chanita Hughes, Susan K. Peterson, Amelie G. Ramírez, Kipling J. Gallion, Paige A. Green, Celette Sugg Skinner, Deborah J. Bowen · 2004 · Cancer Epidemiology Biomarkers & Prevention
  23. Uptake of Offer to Receive Genetic Information about BRCA1 and BRCA2 Mutations in an Australian Population-Based Study
    Louise Anne Keogh, Melissa C. Southey, Judi Maskiell, Mary‐Anne Young, Clara Gaff, Judy Kirk, Kathy Tucker, Doreen Rosenthal, Margaret R.E. McCredie, Graham G. Giles et al. · 2004 · Cancer Epidemiology Biomarkers & Prevention
  24. The risk of primary and contralateral breast cancer after ovarian cancer in <i>BRCA1</i>/<i>BRCA2</i> mutation carriers: Implications for counseling
    Vencken, Peggy M. L. H., Kriege, Mieke, Hooning, Maartje, Menke‐Pluymers, Marian B., Heemskerk‐Gerritsen, Bernadette A. M., van Doorn, Lena C., Collée, Margriet M., Jager, Agnes, van Montfort, Cees, Burger, Curt W. et al. · 2013 · Cancer
  25. Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer
    Puja Bharucha, Kellie E. Chiu, Fabienne M. François, Jessica L. Scott, Gauri R. Khorjekar, Nikki P. Tirada · 2020 · Radiographics
  26. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care
    Rita Kukafka, Samuel S. Pan, Thomas B. Silverman, Tianmai Zhang, Wendy K. Chung, Mary Beth Terry, Elaine M. Fleck, Richard G. Younge, Meghna S. Trivedi, Julia Elizabeth McGuinness et al. · 2022 · JAMA Network Open
  27. Impact of DNA damage repair alterations on prostate cancer progression and metastasis
    Natalia Lukashchuk, Alan Barnicle, Carrie A. Adelman, Joshua Armenia, Jinyu Kang, J. Carl Barrett, Elizabeth A. Harrington · 2023 · Frontiers in Oncology
  28. Arsenic exposure alters expression of cell cycle and lipid metabolism genes in the liver of adult zebrafish (Danio rerio)
    Patrick Carlson, Rebecca J. Van Beneden · 2013 · Aquatic Toxicology
  29. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
    Pascal Pujol, Dominique Stoppa‐Lyonnet, Thierry Frébourg, J. Blin, Marie‐Christine Picot, Christine Lasset, Catherine Dugast, Pascaline Berthet, Brigitte Bressac–de Paillerets, Hagay Sobol et al. · 2013 · Breast Cancer Research and Treatment
  30. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing
    Guoli Li, Xinwu Guo, Lili Tang, Ming Chen, Xipeng Luo, Limin Peng, Xunxun Xu, Shouman Wang, Zhi Qiang Xiao, Wenjun Yi et al. · 2017 · Journal of Cancer Research and Clinical Oncology
  31. Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
    Irit Ben‐Aharon, Mattan Levi, David Margel, Rinat Yerushalmi, Shulamith Rizel, Shlomit Perry, Eran Sharon, Noa Hasky, Ronit Abir, B. Fisch et al. · 2018 · Oncotarget
  32. Trends in BRCA Test Utilization in an Integrated Health System, 2005–2015
    Sarah A. Knerr, Erin J. Aiello Bowles, Kathleen A. Leppig, Diana S.M. Buist, Hongyuan Gao, Karen J. Wernli · 2019 · JNCI Journal of the National Cancer Institute
  33. Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations
    Natasha Caminsky, Eliseos J. Mucaki, Ami M. Perri, Ruipeng Lu, Joan H.M. Knoll, Peter K. Rogan · 2016 · Human Mutation
  34. Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib
    Akshay D. Pathade, Nagavendra Kommineni, Upendra Bulbake, Mohit M. Thummar, Gananadhamu Samanthula, Wahid Khan · 2019 · AAPS PharmSciTech
  35. Committee Opinion No. 634
    2015 · Obstetrics and Gynecology
  36. Screening behavior in women at increased familial risk for breast cancer
    Yoland C. Antill, John Reynolds, Mary Anne Young, Judy Kirk, Kathy Tucker, Tarli L. Bogtstra, Shirley Wong, Tracy E Dudding, Juliana L Di Iulio, Kelly‐Anne Phillips · 2006 · Familial Cancer
  37. Management of women at high risk of breast cancer
    Anne Caroline Armstrong, D. Gareth Evans · 2014 · BMJ
  38. Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations
    Jennifer S. Lee, Esther M. John, Valerie M. McGuire, Anna Felberg, Kimberly Laskie Ostrow, Richard A. DiCioccio, Frederick P. Li, Alexander Miron, Dee W. West, Alice S. Whittemore · 2006 · Cancer Epidemiology Biomarkers & Prevention
  39. The occurrence of germline BRCA1 and BRCA2sequence alterations in Slovenian population
    Vida Stegel, Mateja Krajc, Janez Žgajnar, Erik Teugels, Jacques De Grève, Marko Hočevar, Srdjan Novaković · 2011 · BMC Medical Genetics
  40. The impact of receiving genetic test results on general and cancer‐specific psychologic distress among members of an African‐American kindred with a BRCA1 mutation
    Anita Yeomans Kinney, Lindsey E. Bloor, Diptasri M. Mandal, Sara Ellis Simonsen, Bonnie Jeanne Baty, Richard Holubkov, Kate Seggar, Susan L. Neuhausen, Ken Robert Smith · 2005 · Cancer
  41. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer
    Akiyoshi Kasuga, Takeshi Okamoto, Shohei Udagawa, Chinatsu Mori, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Tsuyoshi Takeda, Masato Matsuyama, Takashi Sasaki et al. · 2022 · International Journal of Molecular Sciences
  42. Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value
    Xuanwen Bao, Kun Wang, Ming Liu, Bin Li, Hongwei Wang, Kemin Jin, Xiaoluan Yan, Hangyu Zhang, Quan Bao, Da Xu et al. · 2022 · Frontiers in Cell and Developmental Biology
  43. Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.
    Kelly A. Metcalfe, Parviz Ghadirian, Barry P. Rosen, William David Foulkes, Charmaine Kim‐Sing, Andrea F. Eisen, Peter Ainsworth, Doug E. Horsman, Christine M. Maugard, Diane Michele Provencher et al. · 2007 · PubMed Central
  44. A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations
    Ian Bosdet, Roderick Docking, Yaron S.N. Butterfield, Andrew J. J. Mungall, Thomas Zeng, Robin Coope, Erika Yorida, Katie Chow, Miruna Bala, Sean S Young et al. · 2013 · Journal of Molecular Diagnostics
  45. Aggregation of Ovarian Cancer with Breast, Ovarian, Colorectal, and Prostate Cancer in First-degree Relatives
    Ko‐Hui Tung · 2004 · American Journal of Epidemiology
  46. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology
    Shane Richard Stecklein, Roy A. Jensen · 2012 · Translational research
  47. On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children
    Beth N. Peshkin, Tiffani A. DeMarco, Kenneth P. Tercyak · 2009 · Familial Cancer
  48. Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Gabriela Torres-Mejı́a, Robert Royer, Marcia Llacuachaqui, Mohammad Reza Akbari, Anna R. Giuliano, Louis Martínez-Matsushita, Angélica Ángeles-Llerenas, Carolina Ortega-Olvera, Elad Ziv, Eduardo Cesar Lazcano-Ponce et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention
  49. Practical aspects of genetic counseling in breast cancer: Lights and shadows
    Alexandre Christinat, Olivia Pagani · 2013 · The Breast
  50. The Dose–Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial
    Justin C. Brown, Despina Kontos B, Mitchell D. Schnall, Shandong Wu, Kathryn H. Schmitz · 2016 · Cancer Prevention Research
  51. Tumor characteristics and prognosis in familial breast cancer
    Grazia Arpino, Matilde Pensabene, Caterina Condello, Raffaella Ruocco, Ilaria Cerillo, Rossella Lauria, Valeria Forestieri, Mario Giuliano, Carmine De Angelis, Maurizio Montella et al. · 2016 · BMC Cancer
  52. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
    Sanna Hallamies, Liisa M. Pelttari, Paula Poikonen‐Saksela, Antti Pekka Jekunen, Arja Jukkola‐Vuorinen, Päivi Auvinen, CARL P. BLOMQVIST, Kristiina Aittomäki, Johanna Mattson, Heli A. Nevanlinna · 2017 · BMC Cancer
  53. Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data
    Elodie Chartron, Charles G. Theillet, Séverine Guiu, William Jacot · 2018 · Critical Reviews in Oncology/Hematology
  54. Shared Genetics Between Age at Menopause, Early Menopause, POI and Other Traits
    Yvonne V. Louwers, Jenny A. Visser · 2021 · Frontiers in Genetics
  55. Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs
    Kevin Wu, Lucas Rodrigues, Gerald S Post, Garrett Harvey, Michelle E. White, Aubrey Miller, Lindsay Lambert, Benjamin Lewis, Christina Lopes, James Zou · 2023 · npj Precision Oncology
  56. Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer
    Lorenzo Melchor, Emiliano Honrado, Jia Huang, Sara Álvarez, Tara L. Naylor, María J. García, Ana Osório, David Blesa, Michael R. Stratton, Barbara L. Weber et al. · 2007 · Clinical Cancer Research
  57. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years
    D. Gareth Evans, Fiona I. Lalloo, Penelope Hopwood, A. Maurice, Andrew D. Baildam, A. Brain, Lester C. Barr, Anthony Howell · 2005 · European Journal of Surgical Oncology
  58. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history
    Theodore Anagnostopoulos, Maroulio Pertesi, Irene Konstantopoulou, Sofia Armaou, Smaragda Kamakari, George Nasioulas, A E Athanasiou, Alexander Dobrovic, Mary‐Anne Young, David E. Goldgar et al. · 2007 · Breast Cancer Research and Treatment
  59. Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women with a BRCA1 or BRCA2 Mutation
    Amy Finch, Mario E. Beiner, Jan Lubiński, Henry T. Lynch, Pål Møller, Barry P. Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William David Foulkes et al. · 2006 · Obstetrical & Gynecological Survey
  60. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2genes
    Heather Hondow, Stephen B. Fox, Gillian Mitchell, Rodney John Scott, Victoria Beshay, Stephen Q. Wong, kConFab Investigators, Alexander Dobrovic · 2011 · BMC Cancer
  61. Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update
    Ophira Ginsburg, Parviz Ghadirian, Jan Lubiński, Cezary Cybulski, Henry T. Lynch, Susan L. Neuhausen, Charmaine Kim‐Sing, Mark E. Robson, Susan M. Domchek, Claudine J. Isaacs et al. · 2008 · Breast Cancer Research and Treatment
  62. Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study
    Virginie Caux‐Moncoutier, Sabine Pagès-Berhouet, Dorothée Michaux, Bernard Jean Roger Asselain, Laurent Castéra, Antoine De Pauw, Bruno Buecher, Marion Gauthier‐Villars, Dominique Stoppa‐Lyonnet, Claude Houdayer · 2009 · European Journal of Human Genetics
  63. MR Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
    Christiane Katharina Kuhl · 2006 · Magnetic Resonance Imaging Clinics of North America
  64. Clinical Management of Hereditary Breast Cancer Syndromes
    Amy Sanders Clark, Susan M. Domchek · 2011 · Journal of Mammary Gland Biology and Neoplasia
  65. Ovarian cancer susceptibility alleles and risk of ovarian cancer inBRCA1andBRCA2mutation carriers
    Susan J. Ramus, Antonis C. Antoniou, Karoline B. Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, Lesley McGuffog, Olga M. Sinilnikova, Sue C. Healey, Daniel Barrowdale et al. · 2012 · Human Mutation
  66. Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
    Milagros González‐Rivera, Miriam Lobo, Sara López‐Tarruella, Yolanda Jerez, Marı́a del Monte-Millán, Tatiana Massarrah, Rocío Ramos‐Medina, Inmaculada Ocaña, Antoni C. Picornell, Sonia Santillán Garzón et al. · 2016 · Breast Cancer Research and Treatment
  67. Therapeutic targeting and patient selection for cancers with homologous recombination defects
    Francien Talens, Mathilde Jalving, Jourik A. Gietema, Marcel A.T.M. van Vugt · 2017 · Expert Opinion on Drug Discovery
  68. Ovarian Cancer Prevention in High-risk Women
    Sarah Madhu Temkin, Jennifer Bergstrom, Goli Samimi, Lori M. Minasian · 2017 · Clinical Obstetrics & Gynecology
  69. Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
    Anna Coppa, Arianna Nicolussi, Sonia D'inzeo, Carlo Capalbo, Francesca Belardinilli, Valeria Colicchia, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Christian Rinaldi et al. · 2017 · Cancer Medicine
  70. Taking stock: A systematic review of archaeological evidence of cancers in human and early hominin remains
    Kathryn J. Hunt, Charlotte Ann Roberts, Casey L. Kirkpatrick · 2018 · International Journal of Paleopathology
  71. Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation
    Ian M. Frayling, Victor‐Felix Mautner, Rick van Minkelen, Roope A. Kallionpää, Safiye Aktaş, Diana Baralle, Shay Ben‐Shachar, Alison Callaway, Harriet Cox, Diana Eccles et al. · 2018 · Journal of Medical Genetics
  72. Association of BRCA Mutations and Anti-müllerian Hormone Level in Young Breast Cancer Patients
    Kyung-A Son, Dong‐Yun Lee, DooSeok Choi · 2019 · Frontiers in Endocrinology
  73. BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
    Munir Ahmad Abu-Helalah, Belal Azab, Rasmi Mubaidin, Dema Ali, Hanan D. Jafar, Hussam Ahmad Alshraideh, Nizar Drou, Abdalla Awidi · 2020 · Scientific Reports
  74. How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?
    Meghan Garstka, Anthony Henriquez, Bridget N. Kelly, Alexandra J. Webster, Jasmine A. Khubchandani, Kevin S. Hughes, Anvy Nguyen, Tawakalitu Omosalewa Oseni, Michelle Connolly Specht, Suzanne B. Coopey et al. · 2021 · Annals of Surgical Oncology
  75. BRCA1: An Endocrine and Metabolic Regulator
    Haim Werner · 2022 · Frontiers in Endocrinology
  76. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Lu Yao, Jie Sun, Juan Zhang, Yingjian He, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin et al. · 2016 · Breast Cancer Research and Treatment
  77. Brief Report: Towards a dietary prevention of hereditary breast cancer
    Joanne Kotsopoulos, Steven Alexander Narod · 2005 · Cancer Causes & Control
  78. Parlez-vous VUS?
    Gregory M. Cooper · 2015 · Genome Research
  79. The surgical menopause
    Ouma Pillay, Isaac Manyonda · 2022 · Best Practice & Research Clinical Obstetrics & Gynaecology
  80. Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes
    Dawn C. Allain · 2008 · Journal of Molecular Diagnostics
  81. A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor
    M Lee, Matthew J. Daniels, M J Garnett, Ashok R. Venkitaraman · 2011 · Oncogene
  82. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: Effects of oral contraceptive use and parental origin of mutation
    Shiri Bernholtz, Yael Laitman, Bella Kaufman, Shani Paluch–Shimon, Eitan Friedman · 2011 · Breast Cancer Research and Treatment
  83. Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico
    Julie Dutil, Jose L. Colon-Colon, Jaime L. Matta, Rebecca Sutphen, Miguel M. Echenique · 2012 · Cancer Genetics
  84. Disease-specific prospective family study cohorts enriched for familial risk
    John Llewelyn Hopper · 2011 · Epidemiologic Perspectives & Innovations
  85. Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study,
    Shana J. Kim, Anna Zuchniak, Kyoung‐Jin Sohn, Jan Lubiński, Rochelle Demsky, Andrea F. Eisen, Mohammad Reza Akbari, Young‐In Kim, Steven Alexander Narod, Joanne Kotsopoulos · 2016 · American Journal of Clinical Nutrition
  86. Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Lovisa Odén, Mohammad Reza Akbari, Tasnim Zaman, Christian Fridolin Singer, Ping Sun, Steven Alexander Narod, Leonardo Salmena, Joanne Kotsopoulos · 2016 · Oncotarget
  87. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol
    Maria C. Katapodi, Valeria Viassolo, Maria Caiata Zufferey, Christos Nikolaidis, Rosmarie Bührer-Landolt, Nicole Bürki, Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio et al. · 2017 · JMIR Research Protocols
  88. BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
    Cecilie Heramb, Teresia Wangensteen, Eli Marie Grindedal, Sarah Louise Ariansen, Sheba M. Lothe, Ketil Heimdal, Lovise Mæhle · 2018 · Hereditary Cancer in Clinical Practice
  89. Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity
    Aleksandra I. Adamovich, Tapahsama Banerjee, Margaret Wingo, Kathryn Duncan, Jie Ning, Fernanda Martins Rodrigues, Kuan‐lin Huang, Cindy Lee, Feng Chen, Li Ding et al. · 2019 · PLoS Genetics
  90. Changing practice: moving to a specialist nurse-led service for BRCA gene testing
    Nicola Scott, Jackie O'Sullivan, Kristjan Asgeirsson, Douglas R. Macmillan, Emma E. Wilson · 2020 · British Journal of Nursing
  91. Clinical Validity and Clinical Utility of Genetic Tests
    Wylie Burke · 2009 · Current Protocols in Human Genetics
  92. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba
    Rolando Camacho Rodríguez, Antonio Alejandro Esperon, Ramón Ropero, María Caridad Rubio, Ronald Rodriguez, Rosa M. Ortiz, Juan J. Lence Anta, Mario de los Rios, Deyanira Carnesolta, Maria C. del Olivera et al. · 2008 · Familial Cancer
  93. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations
    Murray Joseph Casey, Chhanda Bewtra · 2004 · Familial Cancer
  94. Early Onset Breast Cancer in a Registry-based Sample of African-American Women:BRCAMutation Prevalence, and Other Personal and System-level Clinical Characteristics
    Tuya Pal, Devon E. Bonner, Jongphil Kim, Álvaro N.A. Monteiro, Lisa Jay Kessler, Robert Royer, Steven Alexander Narod, Susan Thomas Vadaparampil · 2013 · The Breast Journal
  95. Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families
    Helena Jernström, T Sandberg, Erika Bågeman, Åke Borg, Hakan Lars Olsson · 2005 · British Journal of Cancer
  96. Is BRCA1/BRCA2‐related breast carcinogenesis estrogen dependent?
    Mehrdad Noruzinia, Isabelle Coupier, Pascal Pujol · 2005 · Cancer
  97. Longer-term influence of breast cancer genetic counseling on cognitions and distress: Smaller benefits for affected versus unaffected women
    Arwen H. Pieterse, Margreet G.E.M. Ausems, Peter M. M. Spreeuwenberg, Sandra van Dulmen · 2011 · Patient Education and Counseling
  98. Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
    Kotsopoulos, Joanne, Singer, Christian, Narod, Steven A. · 2017 · Breast Cancer Research and Treatment
  99. Modeling familial clustered breast cancer using published data.
    M. A. Jonker, Cathrien E. Jacobi, Wilhelmina E. Hoogendoorn, Nico J. D. Nagelkerke, Geertruida H. de Bock, Hans C. van Houwelingen · 2003 · PubMed
  100. Evolution of Premalignant Disease
    Kit Curtius, Nicholas A. Wright, Trevor A. Graham · 2017 · Cold Spring Harbor Perspectives in Medicine